MedTrace Logo

Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.

NCT03000712 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2021-01-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of intra-articular injection of autologous adipose tissue derived mesenchymal stem cells compared after high tibial osteotomy to negative control in the osteoarthritis patients

Conditions

Interventions

BIOLOGICAL

Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml

biological : Autologous Adipose Tissue derived MSCs 1x10\^8cells/3ml drug: saline solution

Sponsors & Collaborators

  • R-Bio

    lead INDUSTRY

Principal Investigators

  • KANGIL KIM, M.D., Ph.D · KyungHee University Gangdong Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-02
Primary Completion
2020-05-22
Completion
2020-05-22

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000712 on ClinicalTrials.gov